Stlmmal-yTo test whether the product of the bcl-2 proto-oncogene blocks clonal deletion of self-reactive B cells, we have generated transgenic mice carrying the bcl-2 gene and the immunoglobulin genes for the anti-erthrocyte 4C8 antibody. In these transgenic mice, donal deletion of self-reactive immature B cells in the bone marrow was not inhibited in spite of expression of the bcl-2 gene. In contrast, self-antigen-induced donal deletion of mature self-reactive Ly-1 B (B1) cells in the peritoneal cavity was inhibited in the transgenic mice. These results indicate that the mechanism for clonal deletion of immature self-reactive B cells in the bone marrow differs from that of mature self-reactive B cells in the periphery.
Ig V gene diversity is amplified by somatic DNA rearrange-. ment in B cell precursors of the bone marrow and fetal liver, and by somatic mutations in mature B cells of the peripheral lymphoid organs. Such amplification of diversity allows the immune system to react with almost all possible foreign antigens. The Ig repertoire amplified by genetic mechanisms, includes Ig reactive to self as well as foreign antigens and thus, without appropriate selection, self-reactive B cells inevitably emerge.Studies on autoantibody transgenic mice (1-5) have clearly demonstrated that self-reactive B cells are surveyed by multiple mechanisms of immunological tolerance (6-8). Soluble self-antigens render self-reactive B cells to an inactive state, in which B cells fail to respond to the stimulation by antigens and T helper cells (clonal anergy). Membrane-bound self-antigens eliminate self-reactive B cells presumably by strong cross-linking of surface Ig (slg) 1 receptors (donal deletion). In transgenic mice which produce autoantibodies reactive to self-antigens expressed in the bone marrow, both bone marrow and peripheral B cells are tolerized by either anergy or deletion, suggesting that the bone marrow immature B cells may be the major target of the B cell tolerance (1, 3, 5). However, the transfer experiment of mature self-reactive B cells into mice producing self-antigens revealed that mature B cells can be also anergized (1). Since self-antigens in the liver elimi-1 Abbreviations used in this paper: Ht, hematocrit; MFI, mean fluorescence intensities; NP, 4-(hydroxy-3-nitrophenyl)acetyl; slg, surface Ig. nated self-reactive B cells in the periphery but not in the bone marrow (9), clonal deletion also appears to take place at some stage after B cells migrate from the bone marrow to the periphery.We have analyzed a transgenic mouse line expressing both H and L chains of the 4C8 antierythrocyte autoantibody in almost all the B cells (5). As is the case for other autoantibody transgenic mice (1, 3), the number of B cells in the bone marrow, spleen, and lymph nodes in these transgenic mice are markedly reduced most likely because of clonal deletion at the immature B cell stage in the bone marrow by interaction with RBCs and/or their precursors. However, mature Ly-1 B cells reacting to RBCs are found in the peritone...